Snowball logo
logo
2CL

BridgeBio Pharma, Inc.

2CL • F
€58.43+€0.59  (1.02%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
2022202320242025TTM
Revenue
Total revenue
77.659.303221.9502.1713.1
COGS
3.4342.4463.87820.9639.66
Gross Profit
74.216.857218481.1673.4
Operating Expenses & Income
Operating Income
(468.4)(599.4)(577.4)(502.1)(477.8)
Total Operating Expenses
546.1608.7799.31,004.11,190.9
R&D Expenses
399.5455.7506.5452505.4
Selling General & Admin Expenses
143.2150.6288.9531.2645.9
Earnings from Continuing Operations
Interest Expense
(80.44)(81.29)(99.29)(178.2)(205.9)
Interest Income
7.54218.0417.2519.8523.48
Income Tax Expense
-----
Net Income
Net Income
(481.2)(643.2)(535.8)(724.9)(691.9)
Supplemental
EBIT
-----
EBITDA
-----
In millions of EUR, except % and values per 1 share